By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AMAG Pharmaceuticals, Inc. 

1100 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-498–3300 Fax: 617-499-3361


SEARCH JOBS

Founded in 1981, AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products.

AMAG currently markets a therapeutic intravenous iron compound for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) and an oral rinse for the management of oral mucositis in the United States. To learn more about our products, click here. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company's commercial footprint and focus on hematology and oncology centers and hospital infusion centers.
Our iron oxide particles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. As a result, products using our core technology are well suited for use in intravenous iron replacement therapy.


Key Statistics


Email: contactus@amagpharma.com
Ownership: Public

Web Site: AMAG
Employees: 51-200
Symbol: AMAG
 




Segment
Pharmaceuticals





Company News
AMAG (AMAG) To Present At Upcoming Investor Conferences 9/2/2015 7:27:25 AM
AMAG (AMAG) Appoints Joseph Vittiglio As General Counsel And Secretary 8/25/2015 7:01:04 AM
GTCR Completes Sale Of Cord Blood Registry To AMAG (AMAG) 8/18/2015 11:31:33 AM
AMAG (AMAG) Completes Acquisition Of Cord Blood Registry 8/18/2015 7:41:33 AM
AMAG (AMAG) Announces Pricing Of Private Offering Of $500 Million Of Senior Notes Due 2023 8/13/2015 7:41:57 AM
AMAG (AMAG) Announces Closing Of $231 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/6/2015 7:56:04 AM
AMAG (AMAG) Announces Proposed Private Offering Of $450 Million Of Senior Notes Due 2023 8/5/2015 7:24:38 AM
AMAG (AMAG) Prices Public Offering Of $201 Million Of Common Stock 7/31/2015 7:08:52 AM
AMAG (AMAG) Announces Proposed Public Offering Of $200 Million Of Common Stock 7/30/2015 6:56:51 AM
AMAG (AMAG) Reports Record Second Quarter 2015 Financial Results 7/23/2015 8:21:06 AM
12345678910...
//-->